Evidence map›Paper›PMID 33994782›Full record

ReviewBioinformatics and biology insights2021

Significance of African Diets in Biotherapeutic Modulation of the Gut Microbiome.

P O Isibor, P A Akinduti, O S Aworunse, J O Oyewale, O Oshamika, H U Ugboko, O S Taiwo, E F Ahuekwe, Y D Obafemi, E A Onibokun and 16 more

Open access · goldAbstract readReview
In one paragraph

Review in Bioinformatics and biology insights, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 1 institution in 1 country.

P O IsiborBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
P A AkindutiBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
O S AworunseBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
J O OyewaleBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
O OshamikaBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
H U UgbokoBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
O S TaiwoBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
E F AhuekweBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.ORCID https://orcid.org/0000-0003-1477-4050
Y D ObafemiBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
E A OnibokunBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
O OziegbeBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
M I OnihaBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.ORCID https://orcid.org/0000-0001-5757-8370
B K OlopadeBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
O M AtolagbeBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
B T AdekeyeBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
I B AjiboyeBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
O A BelloBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
J O PopoolaBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
O I AyandaBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.ORCID https://orcid.org/0000-0001-6881-0999
O O AkinnolaBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
G I OlasehindeBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
A O EniBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
O C NwinyiBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
C A OmonhinminBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.ORCID https://orcid.org/0000-0002-0528-0916
S U OranusiBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.
O O ObembeBiotechnology Research Centre, Department of Biological Sciences, Covenant University, Ota, Nigeria.ORCID https://orcid.org/0000-0002-0396-0483
Covenant University · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diet plays an essential role in human development and growth, contributing to health and well-being. The socio-economic values, cultural perspectives, and dietary formulation in sub-Saharan Africa can influence gut health and disease prevention. The vast microbial ecosystems in the human gut frequently interrelate to maintain a healthy, well-coordinated cellular and humoral immune signalling to prevent metabolic dysfunction, pathogen dominance, and induction of systemic diseases. The diverse indigenous diets could differentially act as biotherapeutics to modulate microbial abundance and population characteristics. Such modulation could prevent stunted growth, malnutrition, induction of bowel diseases, attenuated immune responses, and mortality, particularly among infants. Understanding the associations between specific indigenous African diets and the predictability of the dynamics of gut bacteria genera promises potential biotherapeutics towards improving the prevention, control, and treatment of microbiome-associated diseases such as cancer, inflammatory bowel disease, obesity, type 2 diabetes, and cardiovascular disease. The dietary influence of many African diets (especially grain-base such as millet, maize, brown rice, sorghum, soya, and tapioca) promotes gut lining integrity, immune tolerance towards the microbiota, and its associated immune and inflammatory responses. A fibre-rich diet is a promising biotherapeutic candidate that could effectively modulate inflammatory mediators' expression associated with immune cell migration, lymphoid tissue maturation, and signalling pathways. It could also modulate the stimulation of cytokines and chemokines involved in ensuring balance for long-term microbiome programming. The interplay between host and gut microbial digestion is complex; microbes using and competing for dietary and endogenous proteins are often attributable to variances in the comparative abundances of

Indexed as

endotoxemiahostimmune responseinflammationMicrobiotatherapeutic

Identifiers

PMID33994782
PMCPMC8107938
OpenAlexW3158278598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.